Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

H-P Volz

Showing results (81-90 of 86) with videos related to

Pageof 9
Sort By:
You have reached the last page of results.This site can display upto 86 results.
European Archives of Psychiatry and Clinical Neuroscience|February 3, 1999
31P magnetic resonance spectroscopy in the frontal lobe of major depressed patientsH P Volz, R Rzanny, S Riehemann, et al.
Biological Psychiatry|May 20, 1999
Increase of phosphodiesters during neuroleptic treatment of schizophrenics: a longitudinal 31P-magnetic resonance spectroscopic studyH P Volz, G Rössger, S Riehemann, et al.
Schizophrenia Research|June 20, 1998
High-energy phosphates in the frontal lobe correlate with Wisconsin Card Sort Test performance in controls, not in schizophrenics: a 31phosphorus magnetic resonance spectroscopic and neuropsychological investigationH P Volz, G Hübner, R Rzanny, et al.
European Radiology|March 29, 2003
31P-MR spectroscopy in children and adolescents with a familial risk of schizophreniaR Rzanny, S Klemm, J R Reichenbach, et al.
International Journal of Clinical Pharmacology and Therapeutics|January 30, 2007
Reboxetine and cytochrome P450--comparison with paroxetine treatment in humansU D Kuhn, M Kirsch, U Merkel, et al.
The American Journal of Psychiatry|June 1, 2001
Cerebral phosphate metabolism in first-degree relatives of patients with schizophreniaS Klemm, R Rzanny, S Riehemann, et al.
Pageof 9

Showing results (81-90 of 86) with videos related to

Sort By:
Pageof 9
You have reached the last page of results.This site can display upto 86 results.
European Archives of Psychiatry and Clinical Neuroscience|February 3, 1999
31P magnetic resonance spectroscopy in the frontal lobe of major depressed patientsH P Volz, R Rzanny, S Riehemann, et al.
Biological Psychiatry|May 20, 1999
Increase of phosphodiesters during neuroleptic treatment of schizophrenics: a longitudinal 31P-magnetic resonance spectroscopic studyH P Volz, G Rössger, S Riehemann, et al.
Schizophrenia Research|June 20, 1998
High-energy phosphates in the frontal lobe correlate with Wisconsin Card Sort Test performance in controls, not in schizophrenics: a 31phosphorus magnetic resonance spectroscopic and neuropsychological investigationH P Volz, G Hübner, R Rzanny, et al.
European Radiology|March 29, 2003
31P-MR spectroscopy in children and adolescents with a familial risk of schizophreniaR Rzanny, S Klemm, J R Reichenbach, et al.
International Journal of Clinical Pharmacology and Therapeutics|January 30, 2007
Reboxetine and cytochrome P450--comparison with paroxetine treatment in humansU D Kuhn, M Kirsch, U Merkel, et al.
The American Journal of Psychiatry|June 1, 2001
Cerebral phosphate metabolism in first-degree relatives of patients with schizophreniaS Klemm, R Rzanny, S Riehemann, et al.
Pageof 9